Apollo Hospitals on Monday reported a 52% rise in net profit in Q3FY25 to Rs 372 crore year-on-year (YoY), led by growth in healthcare, specialty chain and pharmacy segments.
The company had reported a net profit of Rs 245 crore in the same quarter last year.
Revenue grew 14% to Rs 5,527 crore in Q3FY25.
Earnings before interest, tax, depreciation and amortization (EBITDA), EBITDA grew 24% to Rs 762 crore in Q3FY25.
Revenue of healthcare business (hospital business) grew 13% to Rs 2,785 crore in Q3FY25. EBITDA margin for healthcare business stood at 24.1%. Overall occupancy in hospitals stood at 68% as against 66% in the same period last year.
This was driven by a robust growth in patient occupancy in hospitals, with inpatient (IP) admissions increasing by 5.4% and outpatient (OP) admissions increasing by 22.8%. Average revenue per occupied bed per day (ARPOB) grew by 7.9% y-o-y to Rs 60,839.
Average length of stay (ALOS) declined from 3.34 days in Q3 FY24 to 3.29 days in Q3 FY25. Apollo Healthco – Digital healthcare and omni-channel pharmacy platform grew 15% y-o-y to Rs 2352.4 crore in Q3 FY25.
Apollo Health Company reported a net profit of Rs 32 crore in Q3 FY 2025 as against a loss of Rs 28 crore in Q3 FY 2024. Apollo 24/7’s gross merchandise value (GMV) grew 11% year-on-year to Rs 760 crore.
